The therapeutic efficacy of Ulinastatin for rats with smoking inhalation injury

International Immunopharmacology

Volumn 14, Issue 3, 2012, Pages 289-295

  Qiu, Xiaochen ^a,b   Ji, Shizhao ^b   Wang, Junjie ^b   Li, Hengyu ^b   Xia, Ting ^b   Pan, Bohan ^b   Xiao, Shichu ^b   Xia, Zhaofan ^b  

^a 309TH HOSPITAL OF PLA   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Inflammatory response; Smoke inhalation; Ulinastatin

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOKINE; HYDROXYPROLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; PROTEIN; STRESS ACTIVATED PROTEIN KINASE; ULINASTATIN;

ACUTE LUNG INJURY; AMBIENT AIR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; INFLAMMATION; LUNG BURN; LUNG EDEMA; LUNG FIBROSIS; LUNG FUNCTION; LUNG LAVAGE; LUNG PARENCHYMA; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; STAINING; WESTERN BLOTTING;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; COLLAGEN TYPE I; COLLAGEN TYPE III; CYTOKINES; DISEASE MODELS, ANIMAL; FIBROSIS; GLYCOPROTEINS; HYDROXYPROLINE; MALE; PNEUMONIA; RATS; RATS, SPRAGUE-DAWLEY; SMOKE INHALATION INJURY;

EID: 84865319051     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.08.002     Document Type: Article

References (41)

1. S. Rehberg, M.O. Maybauer, P. Enkhbaatar, D.M. Maybauer, Y. Yamamoto, and D.L. Traber Pathophysiology, management and treatment of smoke inhalation injury Expert Rev Respir Med 3 2009 283 297
2. K.Z. Shirani, B.A. Pruitt Jr., and A.D. Mason Jr. The influence of inhalation injury and pneumonia on burn mortality Ann Surg 205 1987 82 87
3. M. Suzuki, N. Aikawa, K. Kobayashi, and R. Higuchi Prognostic implications of inhalation injury in burn patients in Tokyo Burns 31 2005 331 336
4. R. Alcorta Smoke inhalation & acute cyanide poisoning. Hydrogen cyanide poisoning proves increasingly common in smoke-inhalation victims JEMS 29 Suppl. 6-15 2004 [quiz suppl 6-7)]
5. A. Hamahata, P. Enkhbaatar, E.R. Kraft, M. Lange, S.W. Leonard, and M.G. Traber gamma-Tocopherol nebulization by a lipid aerosolization device improves pulmonary function in sheep with burn and smoke inhalation injury Free Radic Biol Med 45 2008 425 433
6. O.L. Syrkina, D.A. Quinn, W. Jung, B. Ouyang, and C.A. Hales Inhibition of JNK activation prolongs survival after smoke inhalation from fires Am J Physiol Lung Cell Mol Physiol 292 2007 L984 L991
7. M. Laffon, J.F. Pittet, K. Modelska, M.A. Matthay, and D.M. Young Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barriers in rabbits Am J Respir Crit Care Med 160 1999 1443 1449
8. K. Murakami, and D.L. Traber Pathophysiological basis of smoke inhalation injury News Physiol Sci 18 2003 125 129
9. J.B. Sterner, T.B. Zanders, M.J. Morris, and L.C. Cancio Inflammatory mediators in smoke inhalation injury Inflamm Allergy Drug Targets 8 2009 63 69
10. J.M. Albright, C.S. Davis, M.D. Bird, L. Ramirez, H. Kim, and E.L. Burnham The acute pulmonary inflammatory response to the graded severity of smoke inhalation injury Crit Care Med 40 2012 1113 1121
11. M. Kurzius-Spencer, K. Foster, S. Littau, K.J. Richey, B.M. Clark, and D. Sherrill Tracheobronchial markers of lung injury in smoke inhalation victims J Burn Care Res 29 2008 311 318
12. T.L. Palmieri, P. Enkhbaatar, R. Bayliss, L.D. Traber, R.A. Cox, and H.K. Hawkins Continuous nebulized albuterol attenuates acute lung injury in an ovine model of combined burn and smoke inhalation Crit Care Med 34 2006 1719 1724
13. H. Nakazawa, T.O. Gustafsson, L.D. Traber, D.N. Herndon, and D.L. Traber alpha-Trinositol decreases lung edema formation after smoke inhalation in an ovine model J Appl Physiol 76 1994 278 282
14. H. Sato, S. Kajikawa, S. Kuroda, Y. Horisawa, N. Nakamura, and N. Kaga Impaired fertility in female mice lacking urinary trypsin inhibitor Biochem Biophys Res Commun 281 2001 1154 1160
15. C. Umeadi, F. Kandeel, and I.H. Al-Abdullah Ulinastatin is a novel protease inhibitor and neutral protease activator Transplant Proc 40 2008 387 389
16. M.J. Pugia, and J.A. Lott Pathophysiology and diagnostic value of urinary trypsin inhibitors Clin Chem Lab Med 43 2005 1 16
17. M. Xu, X.H. Wen, S.P. Chen, X.X. An, and H.Y. Xu Addition of ulinastatin to preservation solution promotes protection against ischemia-reperfusion injury in rabbit lung Chin Med J (Engl) 124 2011 2179 2183
18. H. Katoh, H. Ishikawa, M. Hasegawa, Y. Yoshida, Y. Suzuki, and T. Ohno Protective effect of urinary trypsin inhibitor on the development of radiation-induced lung fibrosis in mice J Radiat Res (Tokyo) 51 2010 325 332
19. K. Inoue, and H. Takano Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders Expert Opin Investig Drugs 19 2010 513 520
20. K. Inoue, H. Takano, A. Shimada, R. Yanagisawa, M. Sakurai, and S. Yoshino Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide Mol Pharmacol 67 2005 673 680
21. C. Gao, Y. Liu, L. Ma, and S. Wang Protective effects of ulinastatin on pulmonary damage in rats following scald injury Burns Mar 26. 2012 [Electronic publication ahead of print]
22. F. Zhu, X. Qiu, J. Wang, Y. Jin, Y. Sun, and T. Lv A rat model of smoke inhalation injury Inhal Toxicol 24 2012 356 364
23. Y. Sun, R. Yang, J.G. Zhong, F. Fang, J.J. Jiang, and M.Y. Liu Aerosolised surfactant generated by a novel noninvasive apparatus reduced acute lung injury in rats Crit Care 13 2009 R31
24. X. Qiu, H. Li, H. Tang, Y. Jin, W. Li, and YuSun Hydrogen inhalation ameliorates lipopolysaccharide-induced acute lung injury in mice Int Immunopharmacol 11 2011 2130 2137
25. P. Chomczynski A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples Biotechniques 15 532-4 1993 6 7
26. H. Shi, L. Dong, Y. Zhang, Y. Bai, J. Zhao, and L. Zhang Protective effect of a coffee preparation (Nescafe pure) against carbon tetrachloride-induced liver fibrosis in rats Clin Nutr 29 2010 399 405
27. W.I. Choi, O. Syrkina, K.Y. Kwon, D.A. Quinn, and C.A. Hales JNK activation is responsible for mucus overproduction in smoke inhalation injury Respir Res 11 2010 172
28. R.A. Cox, A.S. Burke, S. Jacob, G. Oliveras, K. Murakami, and K. Shimoda Activated nuclear factor kappa B and airway inflammation after smoke inhalation and burn injury in sheep J Burn Care Res 30 2009 489 498
29. A. Zhang, S. Hao, J. Bi, Y. Bao, X. Zhang, and L. An Effects of catalpol on mitochondrial function and working memory in mice after lipopolysaccharide- induced acute systemic inflammation Exp Toxicol Pathol 61 2009 461 469
30. P. David, D. Dunsford, J. Lu, and S. Moochhala Animal models of smoke inhalation induced injuries Front Biosci 14 2009 4618 4630
31. A. Thai, J. Xiao, A.J. Ammit, and R. Rohanizadeh Development of inhalable formulations of anti-inflammatory drugs to potentially treat smoke inhalation injury in burn victims Int J Pharm 389 2010 41 52
32. P. Xu, Y. Fang, W. Yu, and C. Gu Protective effects of ulinastatin on lung injury from severe burns in rats J Shanghai Jiaotong Univ (Med Sci) 29 2009 3
33. H. Nakamura, S. Abe, Y. Shibata, M. Sata, S. Kato, and H. Saito Inhibition of neutrophil elastase-induced interleukin-8 gene expression by urinary trypsin inhibitor in human bronchial epithelial cells Int Arch Allergy Immunol 112 1997 157 162
34. J.B. Yu, and S.L. Yao Protective effects of hemin pretreatment combined with ulinastatin on septic shock in rats Chin Med J (Engl) 121 2008 49 55
35. H. Takano, K. Inoue, A. Shimada, H. Sato, R. Yanagisawa, and T. Yoshikawa Urinary trypsin inhibitor protects against liver injury and coagulation pathway dysregulation induced by lipopolysaccharide/D-galactosamine in mice Lab Invest 89 2009 833 839
36. K. Inoue, H. Takano, R. Yanagisawa, M. Sakurai, A. Shimada, and S. Yoshino Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide Exp Biol Med (Maywood) 230 2005 281 287
37. R. Tanaka, M. Fujita, R. Tsuruta, K. Fujimoto, H.S. Aki, and K. Kumagai Urinary trypsin inhibitor suppresses excessive generation of superoxide anion radical, systemic inflammation, oxidative stress, and endothelial injury in endotoxemic rats Inflamm Res 59 2010 597 606
38. P. Molor-Erdene, K. Okajima, H. Isobe, M. Uchiba, N. Harada, and H. Okabe Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression Am J Physiol Heart Circ Physiol 288 2005 H1265 H1271
39. W. Wei, B. Ma, H.Y. Li, Y. Jia, K. Lv, and G. Wang Biphasic effects of selective inhibition of transforming growth factor beta1 activin receptor-like kinase on LPS-induced lung injury Shock 33 2010 218 224
40. H. Okuno, H. Hazama, T. Murase, Y. Shiozaki, and Y. Sameshima Drug metabolizing activity in rats with chronic liver injury induced by carbon tetrachloride: relationship with the content of hydroxyproline in the liver Jpn J Pharmacol 41 1986 363 371
41. Y. Yamauchi, Y. Izumi, M. Inoue, H. Sugiura, T. Goto, and M. Anraku Safety of postoperative administration of human urinary trypsin inhibitor in lung cancer patients with idiopathic pulmonary fibrosis PLoS One 6 2011 e29053